ArticleProceedings of the National Academy of Sciences of the United States of America2019

Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds.

Abimael Cruz-Migoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.